Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4728 stock hub

TPEX/4728 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4728is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

20.8B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4728

In the news

Latest news · TPEX/4728

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E28.7

P25 14.4P50 18P75 31.9

ROE46.4

P25 -16.2P50 0.3P75 9.8

ROIC88.8

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4728 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

TWD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 20B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0004728001
Last refreshed	2026-05-10
Market cap	TWD 20.8B
Price	TWD 382
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/4728
Website	https://www.sunmaxbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.49%
EV Earnings	27.51x
EV/EBIT	20x
EV/EBITDA	18.14x
EV/FCF	26.05x
EV/Sales	9.85x
FCF yield	3.68%
P/B ratio	12.86x
P/E ratio	28.7x
P/S ratio	10.27x
PE Ratio10 Y	97.48x
PE Ratio3 Y	23.53x
PE Ratio5 Y	20.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.27%
EBITDA Margin	52.8%
FCF margin	37.82%
Gross margin	78.41%
Gross Profit	TWD 1.6B
Gross Profit Growth	7.44%
Gross Profit Growth Q	2.44%
Gross Profit Growth3 Y	10.02%
Gross Profit Growth5 Y	17.77%
Net Income	TWD 725.7M
Net Income Growth	6.82%
Net Income Growth Q	5.91%
Net Income Growth Quarters	2%
Net Income Growth Years	6%
Net Income Growth3 Y	10.78%
Net Income Growth5 Y	24.97%
Pretax Margin	50.07%
Profit Margin	35.82%
Profitable Years	7
ROA	29.58
Roa5y	26.11
ROCE	54.56
ROE	46.36
Roe5y	41.85
ROIC	88.84
Roic5y	96.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	28.74%
Cagr15y	20.09%
Cagr1y	-17.06%
Cagr3y	14.99%
Cagr5y	44.35%
Div CAGR10	54.93%
Div CAGR3	35.63%
Div CAGR5	63.96%
EPS Growth	6.82
EPS Growth Q	5.87
EPS Growth Quarters	2
EPS Growth Years	6
EPS Growth3 Y	10.78
EPS Growth5 Y	24.95
FCF Growth	44.84%
FCF Growth Q	-5.83%
FCF Growth3 Y	16.08%
FCF Growth5 Y	24.41%
OCF Growth	47.21%
OCF Growth Q	8.38%
OCF Growth3 Y	8.61%
OCF Growth5 Y	16.37%
Revenue Growth	11.45x
Revenue Growth Q	6.07x
Revenue Growth Quarters	5x
Revenue Growth Years	6x
Revenue Growth3 Y	13.11x
Revenue Growth5 Y	18.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.96
Assets	TWD 2.1B
Cash	TWD 961.6M
Current Assets	TWD 1.1B
Current Liabilities	TWD 293.8M
Debt	TWD 119.3M
Debt EBITDA	TWD 0.11
Debt Equity	TWD 0.07
Debt FCF	TWD 0.16
Equity	TWD 1.6B
Interest Coverage	212.2
Liabilities	TWD 505.6M
Long Term Assets	TWD 980.3M
Long Term Liabilities	TWD 211.8M
Net Cash	TWD 842.3M
Net Cash By Market Cap	TWD 4.05
Net Cash Growth	16.94%
Net Debt EBITDA	TWD -0.79
Net Debt Equity	TWD -0.52
Net Debt FCF	TWD -1.1
Tangible Book Value	TWD 1.6B
Tangible Book Value Per Share	TWD 29.52
WACC	3.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.89
Inventory Turnover	2.82
Net Working Capital	TWD -86.8M
Quick ratio	3.28
Working Capital	TWD 849.3M
Working Capital Turnover	TWD 2.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	0%
Dividend Growth Years	7%
Dividend per share	TWD 12.1
Dividend Years	9
Dividend Yield	3.17%
Ex Div Date	2026-03-31
Last Dividend	TWD 12.1
Payout Frequency	Annual
Payout Ratio	87.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,150.15%
1Y total return	-17.05%
200-day SMA	397.9
3Y total return	52.06%
50-day SMA	390.3
50-day SMA vs 200-day SMA	50under200
5Y total return	526.58%
All Time High	501
All Time High Change	-23.75%
All Time High Date	2025-05-05
All Time Low	21.25
All Time Low Change	1,697.65%
All Time Low Date	2015-05-12
ATR	7.23
Beta	-0.12
Beta1y	-0.04
Beta2y	0.04
Ch YTD	-3.54
High	383
High52	498
High52 Date	2025-05-08
High52ch	-23.37%
Low	350
Low52	350
Low52 Date	2026-05-08
Low52ch	8.06%
Ma50ch	-2.11%
Price vs 200-day SMA	-3.99%
RSI	39.59
RSI Monthly	58.75
RSI Weekly	44.52
Sharpe ratio	-0.13x
Sortino ratio	0.03
Total Return	3.17%
Tr YTD	-0.49
Tr15y	1,458.22%
Tr1m	-0.39%
Tr1w	-0.65%
Tr3m	0.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 998.3M
Operating Income Growth	7.7
Operating Income Growth Q	6.2
Operating Income Growth3 Y	9.14
Operating Income Growth5 Y	24.61
Operating margin	49.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,611,825%
Net Borrowing	-30,084,000
Shares Insiders	17.06%
Shares Institutions	5.73%
Shares Out	54,463,000
Shares Qo Q	0.18%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 766.3M
Average Volume	22,446.2x
Bv Per Share	29.7
CAPEX	TWD -59.6M
Ch10y	882
Ch15y	1,030.2
Ch1m	-0.39
Ch1w	-0.65
Ch1y	-21.8
Ch3m	-2.55
Ch3y	32.64
Ch5y	414.8
Ch6m	-2.3
Change	-0.39%
Change From Open	8.06
Close	383.5
Days Gap	-7.82
Depreciation Amortization	71,497,000
Dollar Volume	28,419,654
Earnings Date	2026-05-12
EBIT	TWD 998.3M
EBITDA	TWD 1.1B
EPS	TWD 13.31
F Score	6
FCF	TWD 766.3M
FCF EV Yield	3.84x
FCF Per Share	TWD 14.07
Financing CF	-663,132,000
Fiscal Year End	December
Founded	2,001
Graham Number	94.31637
Graham Upside	-75.31
Income Tax	TWD 288.8M
Investing CF	-239,956,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Lynch Fair Value	TWD 332
Lynch Upside	-12.99
Ma150	394.4
Ma150ch	-3.14%
Ma20	391.1
Ma20ch	-2.33%
Net CF	-63,876,000
Next Earnings Date	2026-05-12
Open	353.5
P FCF Ratio	27.15
P OCF Ratio	25.19
Payment Date	2026-05-05
Position In Range	96.97
Ppne	911,635,000
Price Date	2026-05-08
Price EBITDA	TWD 19.45
Ptbv Ratio	12.94
Relative Volume	3.93x
Revenue	2,026,164,000x
Tax By Revenue	14.25x
Tax Rate	28.47%
Tr6m	0.78%
Volume	74,397
Z Score	28.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4728 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.2%

$12.1 annual per share

Payout ratio

+87.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+64.0%

7 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2026-03-31

Performance

TPEX/4728 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4728?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.7%

Share of float held by funds and institutions

Insider ownership

+17.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

TPEX/4728 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.6

Neutral momentum band

Price vs 200-day MA

-4.0%

50/200-day relationship not available

Beta (5Y)

-0.12

Less volatile than the market

Sharpe ratio

-0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4728

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4728 stock rating?

tpex/4728 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4728 analysis?

The full report lives at /stocks/tpex/4728/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4728?

The latest report frames tpex/4728 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4728 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.